Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
Active, not recruiting · NCT04578639 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Active, not recruiting | Phase 3 | 2025-06-27 | NCT04578639 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haukeland University Hospital | 163 |
| Helse Stavanger HF | 67 |
| Oslo University Hospital | 327 |
| St. Olavs Hospital | 167 |
| University Hospital of North Norway | 93 |
| University Hospital, Akershus | 87 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akershus University Hospital | Oslo | Norway | 2 |
| Haukeland University Hospital | Bergen | Norway | 52 |
| Karolinska Hospital | Stockholm | Sweden | 3 |
| Molde Sjukehus | Molde | Norway | 2 |
| Nordlandsykehuset HF | Bodø | Norway | 1 |
| Oslo University Hospital HF | Oslo | Norway | 1 |
| Stavanger University Hospital HF | Stavanger | Norway | 1 |
| Sykehuset Namsos | Namsos | Norway | 2 |
| Sykehuset Telemark | Skien | Norway | 2 |
| Sørlandet sykehus | Kristiansand | Norway | 5 |
| University hospital North Norway | Tromsø | Norway | 3 |
| Vestre Viken sykehus | Drammen | Norway | 1 |